Eledon Pharmaceuticals, Inc. SEC filings ELDN
Eledon Pharmaceuticals, Inc. has 614 filings in SEC EDGAR's recent list, going back to Jun 18, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Aug 14, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Aug 19, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 30, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 24, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 17, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Apr 30, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 28, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Apr 2, 2018 | Dec 31, 2017 |
| 10-K/A | Amended annual report | Apr 25, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 3, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 10, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | May 18, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 26, 2015 | Dec 31, 2014 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELDN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404281
- Former names
- Eledon Pharmaceuticals, Inc. (until Oct 30, 2026); Novus Therapeutics, Inc. (until Dec 22, 2020); Tokai Pharmaceuticals Inc (until May 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.